4
Changes in Ownership
Spyre Therapeutics, Inc. Filed Acc 0001140361-17-033210
Options or other derivatives
- Chief Financial Officer and VP acquired 58,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
York Charles N II · Chief Financial Officer and VP
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2017-08-22 | Grant or award : show line 1 in the form Employee Stock Option (right to buy) | +58,500 | 58,500 | D |
Loading xslF345X03/doc1.xml…